IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex

被引:1539
作者
Kotenko, SV [1 ]
Gallagher, G
Baurin, VV
Lewis-Antes, A
Shen, ML
Shah, NK
Langer, JA
Sheikh, F
Dickensheets, H
Donnelly, RP
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Biol, Newark, NJ 07103 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Microbiol Mol Genet & Immunol, Piscataway, NJ 08854 USA
[4] US FDA, Ctr Biol Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ni875
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report here the identification of a ligand-receptor system that, upon engagement, leads to the establishment of an antiviral state. Three closely positioned genes on human chromosome 19 encode distinct but paralogous proteins, which we designate interferon-lambda1 (IFN-lambda1), IFN-lambda2 and IFN-lambda3 (tentatively designated as IL-29, IL- 28A and IL-28B, respectively, by HUGO). The expression of IFN-lambda mRNAs was inducible by viral infection in several cell lines. We identified a distinct receptor complex that is utilized by all three IFN-lambda proteins for signaling and is composed of two subunits, a receptor designated CRF2-12 (also designated as IFN-lambdaR1) and a second subunit, CRF2-4 (also known as IL-10R2). Both receptor chains are constitutively expressed on a wide variety of human cell lines and tissues and signal through the Jak-STAT (Janus kinases-signal transducers and activators of transcription) pathway. This receptor-ligand system may contribute to antiviral or other defenses by a mechanism similar to, but independent of, type I IFNs.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 44 条
[1]   Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice [J].
Angel, J ;
Franco, MA ;
Greenberg, HB ;
Bass, D .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (06) :655-659
[2]  
[Anonymous], [No title captured]
[3]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[4]   Interferons α and β as immune regulators -: A new look [J].
Biron, CA .
IMMUNITY, 2001, 14 (06) :661-664
[5]   Interleukin 20: Discovery, receptor identification, and role in epidermal function [J].
Blumberg, H ;
Conklin, D ;
Xu, WF ;
Grossmann, A ;
Brender, T ;
Carollo, S ;
Eagan, M ;
Foster, D ;
Haldeman, BA ;
Hammond, A ;
Haugen, H ;
Jelinek, L ;
Kelly, JD ;
Madden, K ;
Maurer, MF ;
Parrish-Novak, J ;
Prunkard, D ;
Sexson, S ;
Sprecher, C ;
Waggie, K ;
West, J ;
Whitmore, TE ;
Yao, L ;
Kuechle, MK ;
Dale, BA ;
Chandrasekher, YA .
CELL, 2001, 104 (01) :9-19
[6]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[7]  
Domanski Paul, 1996, Cytokine and Growth Factor Reviews, V7, P143, DOI 10.1016/1359-6101(96)00017-2
[8]  
Dumoutier L, 2002, EUR CYTOKINE NETW, V13, P5
[9]  
Familletti P C, 1981, Methods Enzymol, V78, P387
[10]   The interleukin-10 family of cytokines [J].
Fickenscher, H ;
Hör, S ;
Küpers, H ;
Knappe, A ;
Wittmann, S ;
Sticht, H .
TRENDS IN IMMUNOLOGY, 2002, 23 (02) :89-96